# Ocular Inflammation in Cataract Patients and Response to Treatment With Xiidra

> **NCT04120987** · PHASE4 · WITHDRAWN · sponsor: **Bucci Laser Vision Institute**

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Lifitegrast 5% Ophthalmic Solution

## Key facts

- **NCT ID:** NCT04120987
- **Lead sponsor:** Bucci Laser Vision Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-05-31
- **Primary completion:** 2022-06-25
- **Final completion:** 2022-06-25
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Administrative
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04120987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04120987, "Ocular Inflammation in Cataract Patients and Response to Treatment With Xiidra". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04120987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*